Innovation & intellectual property · 11/10/2019Updated: 10/17/2026 · 1 min read
U.S. Patent Office Grants Interim Extension to ECI Cancer Immunotherapy Patent
Summary
The U.S. Patent and Trademark Office has issued an order granting a one-year interim extension to the term of U.S. Patent No. 6,406,699, which covers ECI Cancer Immunotherapy.
Original source language: Federal Register — Patent and Trademark OfficeOpen original release →